Literature DB >> 21192002

A unique and potent protein binding nature of liposome containing polyethylenimine and polyethylene glycol: a nondisplaceable property.

Yen-Ku Liu1, Yu-Ling Lin, Chia-Hung Chen, Ching-Min Lin, Kuan-Lun Ma, Fu-Hsuan Chou, Jin-Sheng Tsai, Hsin-Yu Lin, Fu-Rong Chen, Tian-Lu Cheng, Chia-Ching Chang, Kuang-Wen Liao.   

Abstract

Most of the currently available targeting vectors are produced via the linkage of targeting molecules. However, the coupling process is complicated, and the covalent linkage may attenuate the activity of certain targeting molecules. In this study, we have developed a cationic liposome complexed with polyethylenimine and polyethylene glycol polymers (LPPC) that can capture various proteins without covalent conjugation. Characterizations of prepared LPPC revealed that the maximal-binding capacity was about 170 µg of bovine serum albumin to 40 µg of sphere-shaped LPPC (180 nm). The proteins were essentially located at or near the surface when analyzed by atomic force or transmission electron microscopy. We demonstrate that polyethylenimine was an essential component to bind the proteins. Upon the saturation of captured proteins, a given protein could not be displaced by other additional proteins and still retained its biological activity. Using a variety of functional proteins, we show some typical examples of the utility of incorporated beta-glucuronidase and antibodies onto the LPPC. The beta-glucuronidase can be used for the study of antigen-antibody interactions, whereas in studies with the antibody complex, we used anti-CD3 as an agonist to stimulate the proliferation of peripheral blood mononuclear cells via a receptor-mediated mechanism and anti-VEGFR for cell staining. In conclusion, the prepared LPPC can provide a platform to capture biologically and biochemically functional proteins on its surface for various applications, such as cell signaling, cell profiling, noncovalent enzyme-linked immunoassays, and others not mentioned.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21192002     DOI: 10.1002/bit.23048

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  13 in total

1.  Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch.

Authors:  Chia-Hung Chen; Yu-Ling Lin; Yen-Ku Liu; Pei-Juin He; Ching-Min Lin; Yi-Han Chiu; Chang-Jer Wu; Tian-Lu Cheng; Shih-Jen Liu; Kuang-Wen Liao
Journal:  Int J Nanomedicine       Date:  2012-02-03

2.  Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex.

Authors:  Yu-Ling Lin; Chia-Hung Chen; Hsin-Yi Wu; Nu-Man Tsai; Ting-Yan Jian; Yuan-Ching Chang; Chi-Hsin Lin; Chih-Hsiung Wu; Fei-Ting Hsu; Ting Kai Leung; Kuang-Wen Liao
Journal:  J Nanobiotechnology       Date:  2016-02-19       Impact factor: 10.435

3.  Development of a computational promoter with highly efficient expression in tumors.

Authors:  Shu-Yi Ho; Bo-Hau Chang; Chen-Han Chung; Yu-Ling Lin; Cheng-Hsun Chuang; Pei-Jung Hsieh; Wei-Chih Huang; Nu-Man Tsai; Sheng-Chieh Huang; Yen-Ku Liu; Yu-Chih Lo; Kuang-Wen Liao
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

4.  Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies.

Authors:  Yu-Ling Lin; Nu-Man Tsai; Chia-Hung Chen; Yen-Ku Liu; Chung-Jen Lee; Yi-Lin Chan; Yu-Shan Wang; Yuan-Ching Chang; Chi-Hsin Lin; Tse-Hung Huang; Chao Ching Wang; Kwan-Hwa Chi; Kuang-Wen Liao
Journal:  J Nanobiotechnology       Date:  2019-02-06       Impact factor: 10.435

5.  Lipo-PEG-PEI complex as an intracellular transporter for protein therapeutics.

Authors:  Yu-Ling Lin; Chia-Hung Chen; Yen-Ku Liu; Tse-Hung Huang; Nu-Man Tsai; Shey-Cherng Tzou; Kuang-Wen Liao
Journal:  Int J Nanomedicine       Date:  2019-02-13

6.  Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules.

Authors:  Shu-Yi Ho; Pin-Rong Chen; Chia-Hung Chen; Nu-Man Tsai; Yu-Hsin Lin; Chen-Si Lin; Cheng-Hsun Chuang; Xiao-Fan Huang; Yi-Lin Chan; Yen-Ku Liu; Chen-Han Chung; Shun-Long Weng; Kuang-Wen Liao
Journal:  J Nanobiotechnology       Date:  2020-04-09       Impact factor: 10.435

7.  Antitumor Effects of N-Butylidenephthalide Encapsulated in Lipopolyplexs in Colorectal Cancer Cells.

Authors:  Kai-Fu Chang; Jinghua Tsai Chang; Xiao-Fan Huang; Yu-Ling Lin; Kuang-Wen Liao; Chien-Wei Huang; Nu-Man Tsai
Journal:  Molecules       Date:  2020-05-21       Impact factor: 4.411

8.  Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme.

Authors:  Yu-Ling Lin; Kai-Fu Chang; Xiao-Fan Huang; Che-Lun Hung; Shyh-Chang Chen; Wan-Ru Chao; Kuang-Wen Liao; Nu-Man Tsai
Journal:  Int J Nanomedicine       Date:  2015-09-28

9.  Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood-Brain Barrier and Suppresses Growth of Glioblastoma.

Authors:  Yu-Ling Lin; Xiao-Fan Huang; Kai-Fu Chang; Kuang-Wen Liao; Nu-Man Tsai
Journal:  Int J Nanomedicine       Date:  2020-01-31

10.  Intracellular Delivery of Proteins into Living Cells by Low-Molecular-Weight Polyethyleneimine.

Authors:  Yueheng Wu; Lin Jiang; Zixuan Dong; Shaoxian Chen; Xi-Yong Yu; Shunqing Tang
Journal:  Int J Nanomedicine       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.